Klebsiella

Klebsiella refers to a genus of bacteria commonly found in the environment and as part of the normal flora in the human gut and skin. While often harmless, certain strains of Klebsiella can cause severe infections, particularly in individuals with weakened immune systems or those in healthcare settings.

Klebsiella

Key Takeaways

  • Klebsiella is a common bacterium that can cause opportunistic infections.
  • Infections frequently occur in healthcare settings, affecting the lungs, urinary tract, bloodstream, and wounds.
  • Symptoms vary widely depending on the site of infection.
  • Transmission typically happens through direct contact with contaminated hands or medical equipment.
  • Treatment primarily involves antibiotics, but antibiotic resistance, especially to carbapenems, poses a significant challenge.

What is Klebsiella?

Klebsiella is a genus of Gram-negative, rod-shaped bacteria belonging to the Enterobacteriaceae family. These bacteria are ubiquitous, found naturally in soil, water, and on various surfaces. In humans, Klebsiella species are a common part of the normal microbial flora in the gastrointestinal tract and on the skin, where they typically do not cause harm. However, under certain conditions, they can become pathogenic, leading to a range of infections.

Klebsiella infections are particularly concerning in healthcare environments, where they are a leading cause of healthcare-associated infections (HAIs). According to the Centers for Disease Control and Prevention (CDC), Klebsiella species are frequently implicated in pneumonia, bloodstream infections, wound or surgical site infections, and urinary tract infections. The ability of these bacteria to form biofilms and their increasing resistance to antibiotics contribute to their clinical significance.

Klebsiella Infection Symptoms and Transmission

The specific Klebsiella infection symptoms depend largely on the site of the infection within the body. Infections can manifest in various ways, ranging from mild to life-threatening. Common infection sites include the lungs (pneumonia), urinary tract, bloodstream, and surgical wounds. Recognizing these symptoms early is crucial for effective management.

Here are some common symptoms based on infection type:

  • Pneumonia: Fever, chills, cough producing thick, bloody sputum, shortness of breath, and chest pain.
  • Urinary Tract Infections (UTIs): Painful or frequent urination, urgency, lower abdominal discomfort, and fever.
  • Bloodstream Infections (Bacteremia): High fever, chills, fatigue, rapid heart rate, and confusion.
  • Wound Infections: Redness, swelling, pain, warmth at the site, and pus discharge.

Klebsiella infections are primarily acquired through direct contact. The bacteria often spread from person to person via contaminated hands of healthcare workers or contact with contaminated surfaces and medical equipment. This explains why they are so prevalent in hospitals and long-term care facilities. Risk factors for developing a Klebsiella infection include prolonged hospitalization, having invasive medical devices such as catheters or ventilators, undergoing surgery, having a weakened immune system, and previous antibiotic use, which can disrupt the body’s natural flora and allow Klebsiella to proliferate.

Klebsiella Treatment Options

Effective Klebsiella treatment options primarily involve the use of antibiotics. The choice of antibiotic depends on the specific type of infection, its severity, and, critically, the susceptibility of the Klebsiella strain to various antimicrobial agents. Healthcare providers typically perform susceptibility testing on bacterial samples to determine which antibiotics will be most effective. This personalized approach is vital due to the growing challenge of antibiotic resistance.

A significant concern in treating Klebsiella infections is the emergence of multidrug-resistant strains, particularly Carbapenem-resistant Klebsiella (CRKP). CRKP strains are resistant to carbapenems, a class of antibiotics often considered a last resort for severe bacterial infections. Treating these resistant strains often requires a combination of antibiotics or newer, more potent antimicrobial drugs. In addition to antibiotics, supportive care, such as fluid management and fever reduction, is essential. Strict infection control measures, including hand hygiene and environmental disinfection, are also critical in preventing the spread of Klebsiella, especially in healthcare settings.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.